Monitor for any new 13D or 13G filings from other holders that could indicate changing ownership dynamics. The exit by a passive manager is routine and does not alter the fundamental outlook.
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Montanova Capital LLC and affiliated entities filed an amended Schedule 13G disclosing they no longer hold any shares of Fulcrum Therapeutics as of September 30, 2026, down from a prior stake. This complete exit by a passive investment manager removes a known holder but does not signal activist intent.
Key Financial Metrics
Key Facts
- Montanova Capital, Averill Master Fund, and Aaron Cowen filed Amendment No. 3 to Schedule 13G on November 13, 2026
- The filing reports 0 shares and 0% beneficial ownership as of September 30, 2026
- The prior filing (not provided) had disclosed a non-zero stake; this amendment reflects a complete exit
- The filing states securities were held in the ordinary course and not for control purposes
- Fulcrum Therapeutics has a market cap of $286M and a normal daily move of 1.8%
Financial Impact
Complete exit by Montanova Capital; prior stake size not disclosed in this filing
Risk Factors
- No material risk identified from this routine passive exit
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000919574-26-007765 |
| Document: p15120066_ex-b.htm | 0000919574-26-007765 |
| Document: 0000919574-26-007765-index-headers.html | 0000919574-26-007765 |
| Document: 0000919574-26-007765-index.html | 0000919574-26-007765 |
| Document: 0000919574-26-007765.txt | 0000919574-26-007765 |
Track record
23 reports on FULC
6 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +7.71% at T+60 after the Jul 15, 2026 report. 7 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $3.72 Now $3.71 −0.27% settles Nov 18
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $3.73 Now $3.71 −0.40% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $3.77 Now $3.71 −1.59% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Viewing Entry $3.77 Now $3.71 −1.59% settles Nov 17
- Nov 12, 20264d ago 425 Neutral 3/10 Entry $3.77 to $3.71 Now $3.71 −1.59% ▼ −1.59% +0.32% vs SPY
- Nov 12, 20264d ago 8-K Neutral 3/10 Entry $3.77 to $3.71 Now $3.71 −1.59% ▼ −1.59% +0.32% vs SPY
- Nov 5, 202612d ago EFFECT Neutral 4/10 Entry $3.68 to $3.70 Now $3.71 +0.82% ▲ +0.54% +0.23% vs SPY
- Nov 3, 202613d ago S-4/A Neutral 5/10 Entry $3.74 to $3.77 Now $3.71 −0.80% ▲ +0.80% −0.85% vs SPY
- Oct 28, 202619d ago SC 13G/A Neutral 2/10 Entry $3.75 to $3.77 Now $3.71 −1.07% ▲ +0.53% +0.92% vs SPY
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $3.75 to $3.77 Now $3.71 −1.07% ▲ +0.53% +0.92% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers